A
Alan Colomo
Researcher at Carlos III Health Institute
Publications - 17
Citations - 1944
Alan Colomo is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Portal venous pressure & Hemodynamics. The author has an hindex of 8, co-authored 16 publications receiving 1709 citations. Previous affiliations of Alan Colomo include University of Barcelona.
Papers
More filters
Journal ArticleDOI
Transfusion strategies for acute upper gastrointestinal bleeding.
Càndid Villanueva,Alan Colomo,Alba Bosch,Mar Concepción,Virginia Hernández-Gea,Carles Aracil,Isabel Graupera,Maria A. Poca,Cristina Alvarez-Urturi,Jordi Gordillo,Carlos Guarner-Argente,Miquel Santaló,Eduardo Muñiz,Carlos Guarner +13 more
TL;DR: As compared with a liberal transfusion strategy, a restrictive strategy significantly improved outcomes in patients with acute upper gastrointestinal bleeding.
Journal ArticleDOI
Acute Hemodynamic Response to β-Blockers and Prediction of Long-term Outcome in Primary Prophylaxis of Variceal Bleeding
Càndid Villanueva,Carles Aracil,Alan Colomo,Virginia Hernández–Gea,Josep M. López–Balaguer,Cristina Alvarez Urturi,Xavier Torras,Joaquim Balanzó,Carlos Guarner +8 more
TL;DR: The acute hemodynamic response to beta-blockers can be used to predict the long-term risk of first bleeding and an HVPG reduction > 10% from baseline is the best target to define response in primary prophylaxis.
Journal ArticleDOI
Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
Virginia Hernández-Gea,Carles Aracil,Alan Colomo,Isabel Garupera,Maria A. Poca,Xavier Torras,Josep Miñana,Carlos Guarner,Càndid Villanueva +8 more
TL;DR: In patients with compensated cirrhosis and large varices treated with β-blockers, an HVPG decrease ≥10% significantly reduces the risk of developing ascitic decompensation and other related complications such as refractory ascites or hepatorenal syndrome.
Journal ArticleDOI
Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review.
Angela Puente,Virginia Hernández-Gea,Isabel Graupera,Marta Roque,Alan Colomo,Maria Poca,Carles Aracil,Ignasi Gich,Carlos Guarner,Càndid Villanueva +9 more
TL;DR: A systematic review to assess the value of combined therapy with EVL and β‐blockers ± ISMN as compared with each treatment alone to prevent rebleeding.
Journal ArticleDOI
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy
C. Villanueva,Carles Aracil,Alan Colomo,J.M. Lopez-Balaguer,M. Piqueras,B. Gonzalez,Xavier Torras,Carlos Guarner,Joaquim Balanzó +8 more
TL;DR: HVPG monitoring of therapy to prevent variceal rebleeding provides strong prognostic information and treatment of nonresponders to β‐blockers’±“nitrates has not been clarified.